DexCom Inc. is set to attend the 85th Scientific Sessions of the American Diabetes Association $(ADA.AU)$ in Chicago. During the event, which will take place on June 21, Dexcom will present extensive clinical data demonstrating the benefits of continuous glucose monitoring (CGM) for individuals living with Type 2 diabetes. Additionally, Grammy-nominated singer and Dexcom Warrior Lance Bass will share his personal experiences with CGM during a panel discussion.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250618841089) on June 18, 2025, and is solely responsible for the information contained therein.